Dual Targeting of BRAFV600E and Ferroptosis Results in Synergistic Anticancer Activity via Iron Overload and Enhanced Oxidative Stress
Jiangnan Hu, Chandrayee Ghosh, Tejinder Pal Khaket, Zhongyue Yang, Yasmine Tabdili, Eden Demissie Alamaw, Myriem Boufraqech, Scott J. Dixon, Electron Kebebew
This study shows that combining BRAFV600E inhibition with ferroptosis induction synergistically kills anaplastic thyroid cancer cells by increasing iron and oxidative stress.
Journal of Experimental & Clinical Cancer Research · Jan 7, 2026Peer-reviewedCancer Biology